Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX in upper facial lines
NCT06218251Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Feb 2024
- Primary completion
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of botulinum toxin in upper facial lines, sponsored by AbbVie Inc.. Started Feb 2024; status: completed.
02
Drugs
botulinum toxin
03
Conditions
upper facial lines
Beyond the preview
Go deeper on NCT06218251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06218251.